Repeated Transarterial Radioembolization Adverse Event and Hepatotoxicity Profile in Cirrhotic Patients With Hepatocellular Carcinoma: A Single-Center Experience-Reference-Cited by-同舟云学术

Repeated Transarterial Radioembolization Adverse Event and Hepatotoxicity Profile in Cirrhotic Patients With Hepatocellular Carcinoma: A Single-Center Experience

Published:2022-03-28 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Reed Dustin K,Stewart William H,Banta Travis,Lirette Seth T,Campbell Garth S,Patel Akash

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference20 articles.

1. Future of hepatocellular carcinoma incidence in the United States forecast through 2030;Petrick JL;J Clin Oncol,2016

2. Yttrium-90 radioembolization after local hepatic therapy: how prior treatments impact patient selection, dosing, and toxicity;Kessler J;Tech Vasc Interv Radiol,2019

3. Radioembolization-induced liver disease: a systematic review;Braat MN;Eur J Gastroenterol Hepatol,2017

4. Safety of repeated yttrium-90 radioembolization;Lam MG;Cardiovasc Intervent Radiol,2013

5. Radioembolization-induced chronic hepatotoxicity: a single-center cohort analysis;Currie BM;J Vasc Interv Radiol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma;Journal of Personalized Medicine;2024-07-14

2. Radioembolisation mit Harz- und Glas-Mikrosphären;Radiopraxis;2024-05-31

3. Prä- und posttherapeutische Dosimetrie der Radioembolisation;Angewandte Nuklearmedizin;2023-12

4. Radioembolisation mit Harz- und Glas-Mikrosphären;Angewandte Nuklearmedizin;2023-12